Acerca deste livro eletrónico
Cancer Theranostics describes the identification of novel biomarkers to advance molecular diagnostics of cancer. The book encompasses new molecular imaging probes and techniques for early detection of cancer, and describes molecular imaging-guided cancer therapy. Discussion also includes nanoplatforms incorporating both cancer imaging and therapeutic components, as well as clinical translation and future perspectives.
- Supports elimination of multi-step approaches and reduces delays in treatments through combinatorial diagnosis and therapy
- Fully assesses cancer theranostics across the emergent field, with discussion of biomarkers, molecular imaging, imaging guided therapy, nanotechnology, and personalized medicine
- Content bridges laboratory, clinic, and biotechnology industries to advance biomedical science and improve patient management
Acerca do autor
Xiaoyuan (Shawn) Chen, PhD, is a Senior Investigator and Chief of the Laboratory of Molecular Imaging and Nanomedicine (LOMIN) at the National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH). He is also founding editor of journal Theranostics. He holds a PhD in Chemistry from the University of Idaho.
Stephen T.C. Wong, PhD (Computer Science), PE (Electrical Engineering), is John S. Dunn Distinguished Endowed Chair of Biomedical Engineering at Houston Methodist Hospital, the Founding Chair of Department of Systems Medicine and Bioengineering at Houston Methodist Research Institute, and a Professor of Radiology, Neurosciences, Pathology, and Laboratory Medicine at Weill Cornell Medical College.
